tough decisions

Greentown Labs reduces roles at Houston, Boston incubators

The cuts to positions affects both Greentown Labs locations. Photo via Greentown

Greentown Labs has announced a reduction in its staff, which affects both of its locations.

In a letter addressed to the Greentown Labs community, the organization's CEO and President Kevin Knobloch reported that Greentown will be reducing its staff by 30 percent, eliminating 12 roles in Boston and six in Houston. Knobloch noted changes in leadership, growth of the team, and adjustments following the pandemic.

"Greentown Labs grew rapidly over the past four years in pursuit of advancing its mission to catalyze climate action through entrepreneurship, partnership, and collaboration," Knobloch writes in the letter. "This created a structural deficit where growth outpaced revenue."

The letter did not provide details of which positions were eliminated at either location.

With these resizing of the staff and reduced expenses, Knobloch writes that the organization is positioned well for its future.

"Despite this decision, I remain optimistic about the future for Greentown and the impact we will have on addressing the climate crisis," Knobloch tells the community. "Our mission is as urgent as ever and we remain committed to supporting all of you—our startups—by prioritizing core operations, member services, and strategic partner engagements."

Knobloch took the helm of Greentown last summer. He previously served as chief of staff of the United States Department of Energy in President Barack Obama’s second term.

Trending News

A View From HETI

Syzygy Plasmonics has secured an offtake agreement for 100% of the production from its first commercial SAF plant. Photo courtesy of Syzygy.

Houston-based Syzygy Plasmonics has secured a six-year official offtake agreement for the entire production volume of its first commercial-scale biogas-to-sustainable aviation fuel project in Uruguay, known as NovaSAF-1.

SP Developments Uruguay S.A., a subsidiary of Syzygy, entered into the agreement with Singapore-based commodity company Trafigura, according to a news release. There is also an option for Trafigura to purchase additional volumes from future Syzygy projects.

The first deliveries from the landmark SAF facility are expected in 2028.

“This agreement marks a critical step in our journey toward commercial-scale impact and disrupting the SAF market,” Trevor Best, CEO of Syzygy Plasmonics, said in the news release. “With a signed offtake agreement from a global leader like Trafigura, and after having successfully completed FEED engineering in December, we're now ready to secure financing for the construction of NovaSAF-1 and move our technology from potential into production."

The NovaSAF-1 project will be located in Durazno, Uruguay. The facility will be the world's first electrified biogas-to-SAF facility producing renewable and advanced compliant SAF. Syzygy estimates that the project will produce over 350,000 gallons of SAF annually. The facility is expected to produce SAF with at least an 80 percent reduction in carbon intensity compared to Jet A fuel.

It’s backed by Uruguay’s largest dairy and agri-energy operations, Estancias del Lago. It will also work with Houston-based Velocys, which will provide Fischer-Tropsch technology for the project. Fischer-Tropsch technology converts synthesis gas into liquid hydrocarbons, which is key for producing synthetic fuels like SAF.

Trending News